91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this article, CFO Brendan Brennan discusses the responsibility of CROs in the fight against COVID-19, particularly by helping the most vulnerable populations gain access to vaccines and treatments.
-
In this radio interview briefly discusses the disparity of vaccine rollouts of developed countries compared to less economically developed countries, and the role of 91黑料
-
Dr. Caroline Forkin, VP Clinical Research Services, considers .
This article is taken from European Biopharmaceutical Review October 2021, pages 70-73. Samedan Ltd
-
Nuala Murphy contributes to the Bottom Line BBC4 podcast about the impact of the COVID-19 vaccine on the clinical trial process and whether these changes could work for other drugs.
-
Seth Nelson, Senior Director of Patient Recruitment and Clinical Research Services, provides expert commentary on .
-
Nuala Murphy, President Global Specialty Solutions, contributes to this about accelerating the pace of drug development due to the pandemic.
-
91黑料 CEO Steve Cutler chats with Newsweek, on 91黑料’s role in the development of much needed medicines. .
-
, CEO at 91黑料 plc, about the impact of the COVID pandemic and challenges of running large-scale vaccine trials.
-
Global collaboration: Irish company 91黑料 on scaling up COVID-19 vaccine trials
An interview in which Steve Cutler gives a short overview of 91黑料 and describes the company’s role in the Pfizer/BioNTech trial, explaining how the FDA played a critical role in expediting regulatory approvals.
-
Shelley McLendon, VP of Project Management, Vaccines and Infectious Diseases, outlines best practices that can keep trials running at optimal speed and efficiency, and the benefits of adopting a strategic partnership.
